Searched for
SHARVIL PATEL ZYDUS
Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...- Zydus’ Saroglitazar meets primary goal in global Phase II(b) MASH trialZydus Lifesciences said its drug Saroglitazar Magnesium met the primary goal of a global Phase II(b) trial for MASH, a serious liver diseas...
- Zydus Lifesciences shares drop 3% after Q1 earnings. Here's why Nuvama upgraded rating, hiked targetShares of Zydus Lifesciences saw a decline of more than two percent following the announcement of a notable profit drop. The net profit plu...
- Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection testZydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through ...
- Zydus, Sunshine to set up $20 million pharma JV in Sri LankaIndian pharmaceutical giant Zydus Lifesciences has partnered with Sri Lanka's Sunshine Healthcare Lanka to establish a new manufacturing fa...
- Indian Pharmaceutical Alliance appoints Zydus Lifesciences MD Sharvil Patel as new presidentThe Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel of Zydus Lifesciences as its new President, with Glenn Saldanha of Gle...
- Zydus gets USFDA nod for generic drug to treat multiple sclerosisZydus Lifesciences has secured USFDA approval to market Glatiramer Acetate Injection, a generic version of Copaxone, for treating relapsing...
- Zydus gets Mexican regulatory approval to market cancer treatment productThe product is used in the treatment of breast cancer and advanced gastric cancer. Breast cancer has become the most diagnosed cancer in Me...
- Zydus inks licensing pact with Takeda to sell GERD drug"With a rich legacy in marketing gastrointestinal therapies in India, we have been offering different breakthrough clinical options across ...
- Zydus aims to launch first new drug in US by early 2026Zydus will enter a competitive field, with an FDA decision on CymaBay's PBC drug due in August. Gilead Sciences announced its acquisition o...
- Zydus Lifesciences acquires UK-based LiqMeds Group for Rs 690 croreZydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026 depending on achievement of certain agreed milest...
- Zydus Lifesciences appoints Punit Patel as President & CEO, AmericasBefore joining Zydus, he was the President of Red Oak Sourcing, leading the company's "multibillion-dollar generic portfolio", overseeing a...
- Buy Zydus Lifesciences, target price Rs 470: JM FinancialZydus Lifesciences Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 42548.00 Crore) operating in Phar...
- Zydus buys rights from Pharmacosmos to sell drug to treat anemia in India, NepalMonoFerric injection is a rapid, single dose intravenous therapy used for the treatment of iron deficiency in adult patients when oral iron...
- Zydus Lifesciences Q4 profit declines 41% to Rs 397 crThe company also incurred expenses of Rs 120 crore during the quarter for changes in inventories of finished goods, work-in-progress and st...
- Zydus Cadila now plans to test its Covid-19 vaccine for 5-12 age groupThe pharma major has already covered 800-plus children in 12-18 years clinical trials.
- Cadila's new MD Sharvil Patel aims to double revenues in 5 yearsWith a doctoral degree from University of Sunderland, Sharvil is the third generation Patel to lead Cadila. The company was founded by his ...
- Pankaj Patel steps down as Cadila MD, son Sharvil to take overThe Board of Directors of Cadila Healthcare has unanimously approved the appointment of Sharvil P Patel as the Manging Director of the comp...
- Zydus Cadila acquires six brands from Merck IndiaThe acquired brands Deca-Durabolin, Durabolin, Sustanon, Multiload, Sicastat and Axeten range had clocked sales of Rs 840 million in 2015.
- Zydus launches Tenglyn tablets in Indian marketDrug firm Zydus Cadila has launched its generic Tenglyn tablets belonging to new class of oral anti-diabetic treatment drugs, Gliptins, in ...
Load More
